| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/OXFORDJOURNALS.AJE.A116294 |
| P953 | full work available at URL | http://aje.oxfordjournals.org/cgi/content/abstract/135/4/331 |
| P698 | PubMed publication ID | 1550087 |
| P2093 | author name string | R. J. Prescott | |
| C. V. Ruckley | |||
| F. G. Fowkes | |||
| R. A. Riemersma | |||
| C. C. Macintyre | |||
| E. Housley | |||
| E. H. Cawood | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lipid | Q11367 |
| heart disease | Q190805 | ||
| coronary artery disease | Q844935 | ||
| glucose intolerance | Q2661464 | ||
| P304 | page(s) | 331-340 | |
| P577 | publication date | 1992-02-01 | |
| 1992-02-15 | |||
| P1433 | published in | American Journal of Epidemiology | Q4744243 |
| P1476 | title | Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study | |
| P478 | volume | 135 |
| Q64902434 | A Low-Molecular-Weight Polyethylenimine/pDNA-VEGF Polyplex System Constructed in a One-Pot Manner for Hindlimb Ischemia Therapy. |
| Q92153753 | A Pro-Inflammatory Biomarker-Profile Predicts Amputation-Free Survival in Patients with Severe Limb Ischemia |
| Q32066876 | A long-term study of policosanol in the treatment of intermittent claudication |
| Q46831663 | A study of arteriosclerosis in healthy subjects with HBV and HCV infection |
| Q49304512 | Abnormally Low or High Ankle-Brachial Index Is Associated With the Development of Diabetic Retinopathy in Type 2 Diabetes Mellitus. |
| Q35730146 | Abnormally Low or High Ankle-Brachial Index Is Associated with Proliferative Diabetic Retinopathy in Type 2 Diabetic Mellitus Patients |
| Q36238939 | Age, male gender, and atrial fibrillation predict lower extremity amputation or revascularization in patients with peripheral artery diseases: a population-based investigation |
| Q71564645 | Alcohol intake as a risk factor for peripheral arterial disease in the general population in the Edinburgh Artery Study |
| Q28218702 | Antiplatelet therapy in populations at high risk of atherothrombosis |
| Q48157536 | Approach to smoking cessation in the patient with vascular disease |
| Q45139341 | Associated risk factors for abnormal ankle-brachial index in hemodialysis patients in a hospital |
| Q35627443 | Association of body mass index with peripheral arterial disease in older adults: the Cardiovascular Health Study |
| Q37246522 | Association of insulin resistance and inflammation with peripheral arterial disease: the National Health and Nutrition Examination Survey, 1999 to 2004 |
| Q36027227 | Atherosclerotic disease and risk factor modification in Saudi Arabia: a call to action |
| Q96305191 | Atherosclerotic diseases and lung cancer - a ten-year cross-sectional study in Cyprus |
| Q34022654 | Cigarette smoking, endothelial injury and cardiovascular disease |
| Q33864472 | Comparison of the severity of lower extremity arterial disease in smokers and patients with diabetes using a novel duplex Doppler scoring system |
| Q74660441 | Coronary artery disease in diabetic and nondiabetic patients with lower extremity arterial disease: A report from the Coronary Artery Surgery Study Registry |
| Q27026881 | Criticial limb ischemia: epidemiology |
| Q34255703 | Depression and sexual dysfunction among HIV-positive and HIV-negative men who have sex with men: mediation by use of antidepressants and recreational stimulants |
| Q36817408 | Differential effect of female gender on coronary artery disease and peripheral artery disease |
| Q90219731 | Dyslipidemia Profiles in Patients with Peripheral Artery Disease |
| Q22241786 | ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - Summary |
| Q35547107 | Early-onset peripheral arterial occlusive disease: clinical features and determinants of disease severity and location |
| Q34345325 | Epidemiological research on peripheral vascular disease |
| Q41388533 | Epidemiology of non-insulin-dependent diabetes mellitus and its macrovascular complications. A basis for the development of cost-effective programs |
| Q95840512 | Epidemiology of peripheral artery disease in Palestine |
| Q41559774 | Epidemiology of peripheral vascular disease |
| Q77052053 | Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance |
| Q35200722 | Epidemiology of smoking-induced cardiovascular disease |
| Q57416373 | Femoral atherosclerosis in an older British population: prevalence and risk factors |
| Q77111464 | Flow-mediated vasodilation of the femoral and brachial artery induced by exercise in healthy nonsmoking and smoking men |
| Q84561892 | Frequency and predictors of endoleaks and long-term patency after covered stent placement for the treatment of intracranial aneurysms: a prospective, non-randomised multicentre experience |
| Q33735811 | Ideal cardiovascular health and peripheral artery disease in African Americans: Results from the Jackson Heart Study |
| Q35562469 | Influence of Smoking on Predictors of Vascular Disease |
| Q37407755 | Interleukin-6 receptor pathways in abdominal aortic aneurysm |
| Q34585229 | Intermittent claudication: pharmacoeconomic and quality-of-life aspects of treatment |
| Q36596899 | Knowledge and attitude of physicians in a major teaching hospital towards atherosclerotic risk reduction therapy in patients with peripheral arterial disease. |
| Q36822917 | Leptospirosis and Peripheral Artery Occlusive Disease: A Nationwide Cohort Analysis |
| Q50896174 | Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjects. |
| Q90321036 | Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence |
| Q37200758 | Management of cardiovascular risk factors by primary care physicians in patients with peripheral arterial disease |
| Q73712809 | Methylene tetrahydrofolate reductase (MTHFR) and nitric oxide synthase (ecNOS) genes and risks of peripheral arterial disease and coronary heart disease: Edinburgh Artery Study |
| Q33844756 | Mortality following operations for lower extremity peripheral arterial disease |
| Q55267162 | Multi-Task Learning to Identify Outcome-Specific Risk Factors that Distinguish Individual Micro and Macrovascular Complications of Type 2 Diabetes. |
| Q33895487 | New semiquantitative ultrasonographic score for peripheral arterial disease assessment and its association with cardiovascular risk factors |
| Q34434785 | Optimal management of infrainguinal arterial occlusive disease |
| Q47723774 | Outcome of revascularization procedures for peripheral arterial occlusive disease in Ontario between 1991 and 1998: a population-based study |
| Q34513905 | Overview of classification systems in peripheral artery disease |
| Q34930007 | PAD. Epidemiology and pathophysiology |
| Q77053565 | Peripheral arterial disease |
| Q51591976 | Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn study. |
| Q37896022 | Peripheral arterial disease--what do we need to know? |
| Q37883007 | Peripheral artery disease. Part 1: clinical evaluation and noninvasive diagnosis |
| Q30241154 | Peripheral artery disease: epidemiology and global perspectives |
| Q34314049 | Peripheral vascular disease and hypertension: a forgotten association? |
| Q42578565 | Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell prospective heart disease study |
| Q33702119 | Physical activity and risk of peripheral arterial disease in the general population: Edinburgh Artery Study |
| Q44410852 | Pulse pressure and subclinical peripheral artery disease |
| Q71969930 | Risk Factor Profile of Nonsmokers with Peripheral Arterial Disease |
| Q50967816 | Risk factors associated with the development of peripheral arterial disease in smokers: a case-control study. |
| Q37715525 | Risk factors for incident peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation in type 2 Diabetes (BARI 2D) Trial |
| Q52650244 | Secondhand smoke exposure and risk of incident peripheral arterial disease and mortality: a Scotland-wide retrospective cohort study of 4045 non-smokers with cotinine measurement. |
| Q35188903 | Smokers' relative risk for aortic aneurysm compared with other smoking-related diseases: a systematic review |
| Q30744649 | Smoking Cessation Strategies in Patients with Peripheral Arterial Disease: An Evidence-based Approach |
| Q47762914 | Smoking, hemorheologic factors, and progression of peripheral arterial disease in patients with claudication |
| Q35165801 | Suboptimal use of risk reduction therapy in peripheral arterial disease patients at a major teaching hospital |
| Q34761652 | Temporal trend analysis of avoidable mortality in Taiwan, 1971-2008: overall progress, with areas for further medical or public health investment |
| Q64947177 | The Influence of Physical Exercise on Smoking Patients with Peripheral Arterial Disease. |
| Q36047996 | The Risk of Peripheral Arterial Disease after Parathyroidectomy in Patients with End-Stage Renal Disease |
| Q33269431 | The association of the ankle-brachial index with incident coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study, 1987-2001. |
| Q41119594 | The benefits of stopping smoking and the role of nicotine replacement therapy in older patients |
| Q36094937 | The effects of smoking status on walking ability and health-related quality of life in patients with peripheral arterial disease |
| Q50616441 | The influence of smoking cessation and hypertriglyceridaemia on the progression of peripheral arterial disease and the onset of critical ischaemia. |
| Q40802367 | The prevention of cardiovascular disease. Emphasis on secondary prevention. |
| Q33234885 | The reliability of the ankle-brachial index in the Atherosclerosis Risk in Communities (ARIC) study and the NHLBI Family Heart Study (FHS) |
| Q35617377 | The use of animal models in developing the discipline of cardiovascular tissue engineering: a review. |
| Q58717282 | The use of ankle brachial pressure indices in a cohort of black African diabetic patients |
| Q24201969 | Treatment of hypertension in peripheral arterial disease |
| Q24240538 | Treatment of hypertension in peripheral arterial disease |
| Q24248743 | Treatment of hypertension in peripheral arterial disease |
| Q71407507 | Unravelling the familial tendency to aneurysmal disease: popliteal aneurysm, hypertension and fibrillin genotype |
| Q71991836 | Upper-limb arterial disease in women treated for breast cancer |
| Q33906348 | Use of non-steroidal anti-inflammatory drugs and risk of incident myocardial infarction and heart failure, and all-cause mortality in the Australian veteran community |
| Q51036937 | Variation in cardiovascular risk factors by angiographic site of lower limb atherosclerosis. |
| Q35106315 | Vascular biology of metabolic syndrome |
| Q50853928 | [Epidemiology and prognosis of peripheral obliterative arteriopathy]. |
| Q78851853 | [Epidemiology of and risk factors for lower limb arteriopathy obliterans] |
| Q77652812 | [Quality of life and peripheral obliterative arteriopathy. Perspective for the future] |
Search more.